PharmaCyte Biotech (PMCB) EPS (Basic) (2010 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly EPS (Basic) of -$0.58 for Q2 2026, down 148.56% year-over-year from $1.2 in Q2 2025, and down 246.21% quarter-over-quarter from -$0.17 in Q1 2026.
PharmaCyte Biotech (PMCB) EPS (Basic) (2010 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported EPS (Basic) for 17 consecutive years, with -$0.58 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) fell 148.56% year-over-year to -$0.58; the TTM figure through Apr 2026 stood at -$2.77 (down 186.9% YoY), while the FY2026 annual figure was -$2.77, down 186.9% from the prior year.
- EPS (Basic) retreated to -$0.58 in Q2 2026 per PMCB's latest filing, from -$0.17 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.62 in Q3 2024 and bottomed at -$1.24 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.13 across 5 years, with a median of -$0.21 in 2023.
- On a YoY basis, EPS (Basic) climbed as much as 586.79% in 2024 and fell as far as 3990.47% in 2024.
- PharmaCyte Biotech's EPS (Basic) stood at -$0.09 in 2022, then tumbled by 182.01% to -$0.26 in 2023, then slumped by 50.39% to -$0.39 in 2024, then sank by 219.67% to -$1.24 in 2025, then surged by 53.03% to -$0.58 in 2026.
- Business Quant data shows PMCB's EPS (Basic) at -$0.58 in Q2 2026, -$0.17 in Q1 2026, and -$1.24 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | PharmaCyte Biotech | 4.44 Mn | 4.44 Mn | - | -0.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.58 |
| Jan 31, 2026 | -0.17 |
| Oct 31, 2025 | -1.24 |
| Jul 31, 2025 | -1.23 |
| Apr 30, 2025 | 1.20 |
| Jan 31, 2025 | -0.44 |
| Oct 31, 2024 | -0.39 |
| Jul 31, 2024 | 2.62 |
| Apr 30, 2024 | -0.27 |
| Jan 31, 2024 | -0.65 |
| Oct 31, 2023 | -0.26 |
| Jul 31, 2023 | -0.54 |
| Apr 30, 2023 | -0.01 |
| Jan 31, 2023 | -0.04 |
| Oct 31, 2022 | -0.09 |
| Jul 31, 2022 | -0.07 |
| Apr 30, 2022 | -0.09 |
| Jan 31, 2022 | -0.04 |
| Oct 31, 2021 | -0.06 |
| Jul 31, 2021 | -0.64 |